Transforming growth factor-ß2 inhibition of corneal endothelial proliferation mediated by prostaglandin
- 1 January 2003
- journal article
- Published by Taylor & Francis in Current Eye Research
- Vol. 26 (6) , 363-370
- https://doi.org/10.1076/ceyr.26.5.363.15442
Abstract
To determine the influence of Prostaglandin (PG) E2 on transforming growth factor (TGF)-beta2-mediated inhibitory effects on the proliferation of corneal endothelial cells (CE). The PGE2 and cell proliferation assays were performed using cultured rabbit corneal endothelium. A PGE2-specific enzyme immunoassay was used to check PGE2 synthesis in supernatants of cells cultured with and without added TGF-beta2 and/or indomethacin. To evaluate the inhibitory effects of PGE2 and TGF-beta2 on CE proliferation, the number of cells grown with exogenous PGE2, or TGF-beta2 with or without indomethacin pretreatment was determined. TGF-beta2, 0.5 to 50 ng/ml, increased the PGE2 secretion of CE dose-dependently in a time-dependent manner. Indomethacin (> or =0.1 microg/ml) inhibited this PGE2 secretion to a low level (around 5-10 ng/ml) in the presence or absence of exogenous TGF-beta2. Both exogenous TGF-beta2 and PGE2 inhibited CE proliferation dose-dependently over a wide range of concentrations. Indomethacin reversed the inhibitory effects of TGF-beta2 but not those of exogenous PGE2. In the medium supplemented with indomethacin, even in the presence of 50 ng/ml of TGF-beta2, CE growth did not differ from control cultures. TGF-beta2 stimulates PGE2 synthesis in CE and inhibits CE proliferation in a dose-dependent manner. Indomethacin extinguishes the inhibitory effects of TGF-beta2 on CE proliferation but not the effect of exogenous PGE2. These data suggest that the antiproliferative effects of TGF-beta2 on CE may be possibly due to TGF-beta2-induced synthesis of PG, most likely PGE2. Inhibition of endogenous prostaglandins synthesis by indomethacin extinguished the inhibitory effects of Transforming Growth Factor-beta2 on corneal endothelium proliferation but not exogenous prostaglandin E2. It suggesting that TGF-beta2-induced autocrine synthesis of PGs, most likely PGE2, may be responsible for the anti-proliferative effects of TGF-beta2 on corneal endothelium.Keywords
This publication has 21 references indexed in Scilit:
- Transforming growth factor-β1 regulation of resting zone chondrocytes is mediated by two separate but interacting pathwaysBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2000
- Effects of prostaglandin E2 on growth, morphology, morphometry and keratin pattern of bovine corneal epithelial cells cultured in vitroAnnals of Anatomy - Anatomischer Anzeiger, 1998
- Presence of Growth Factor in Human VitreousOphthalmologica, 1997
- High total TGF-β2 levels in normal human tearsCurrent Eye Research, 1996
- Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism.Proceedings of the National Academy of Sciences, 1995
- Effects of Transforming Growth Factor β and Interleukin-1β on Expression of Cyclooxygenase 1 and 2 and Phospholipase A2 mRNA in Lung Fibroblasts and Endothelial Cells in CultureBiochemical and Biophysical Research Communications, 1993
- Transforming growth factor-β potentiates epidermal growth factor-induced prostaglandin E2 production in amnion cellsProstaglandins, 1993
- Transforming growth factor β2 differentially modulates interleukin-1 β- and tumour-necrosis-factor-α-stimulated phospholipase A2 and prostaglandin E2 synthesis in rat renal mesangial cellsBiochemical Journal, 1990
- Transforming growth factor-β in human aqueous humorCurrent Eye Research, 1990
- Transforming growth factor-β inhibits prostaglandin production in amnion and A431 cellsProstaglandins, 1989